FDA has granted priority review designation for Merck’s request for a supplemental biologics license application for pembrolizumab to treat Merkel cell carcinoma, a rare skin cancer.
Patients with multiple sclerosis who smoked cigarettes had higher rates of respiratory complications and increased sedentary lifestyle.
Top news of the day from across the health care landscape.
Some older women undergoing chemotherapy for breast cancer may be more susceptible to declining physical function and inability to recover function.
Combined ipilimumab and nivolumab treatment produced durable responses in patients with melanoma brain metastases.
Supplementing a commonly used treatment approach with an additional inhibitor could help overcome resistance in glioblastoma.
Top news of the day from across the health care landscape.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.